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ABSTRACT
Actin is a major cytoskeletal protein in eukaryotes.
Recent studies suggest more diverse functional
roles for this protein. Actin mRNA is known to be
localized to neuronal synapses and undergoes
rapid deadenylation during early developmental
stages. However, its 3’-untranslated region (UTR)
is not characterized and there are no experimentally
determined polyadenylation (polyA) sites in actin
mRNA. We have found that the cytoplasmic b-actin
(Actb) gene generates two alternative transcripts
terminated at tandem polyA sites. We used 3’-
RACE, EST end analysis and in situ hybridization
to unambiguously establish the existence of two
3’-UTRs of varying length in Actb transcript in
mouse neuronal cells. Further analyses showed
that these two tandem polyA sites are used in a
tissue-specific manner. Although the longer 3’-UTR
was expressed at a relatively lower level, it con-
ferred higher translational efficiency to the tran-
script. The longer transcript harbours a conserved
mmu-miR-34a/34b-5p target site. Sequence-
specific anti-miRNA molecule, mutations of the
miRNA target region in the 3’-UTR resulted in
reduced expression. The expression was restored
by a mutant miRNA complementary to the mutated
target region implying that miR-34 binding to Actb
3’-UTR up-regulates target gene expression.
Heterogeneity of the Actb 3’-UTR could shed light
on the mechanism of miRNA-mediated regulation
of messages in neuronal cells.
INTRODUCTION
Actin is an abundantly expressed globular structural pro-
tein found in eukaryotes, involved in muscle contraction,
cell mobility, cytokinesis, organelle movement and main-
tenance of cell shape. In lower organisms like yeast, actin
is coded for by a single gene whereas diﬀerent isoforms of
actin perform diﬀerent functions in higher organisms like
mammals. The expression of cytoplasmic b-actin gene is
generally believed to be constitutive and ubiquitous and it
is well known that it carries out housekeeping functions in
the eukaryotic cell. However, recently, actin has been
shown to play diverse roles besides its housekeeping func-
tions. Presence of actin in the nucleus has been demon-
strated and functionally, it has been shown to interact
with the transcriptional machinery, suggesting a role
in transcriptional regulation (1–5). In several cell types,
including chicken ﬁbroblasts and mammalian neuronal
cells, actin mRNA is known to be selectively localized
to the periphery of the cell. The high conservation of the
30-untranslated region (UTR) of actin in vertebrates led to
the suggestion that they may contain regulatory sequences
(6). Subsequently, it has been demonstrated that a 54-
nucleotide element called the zipcode, immediately follow-
ing the stop codon is necessary for the localization of actin
mRNA (7). Actin is also known to be deadenylated during
early developmental stages along with many other tran-
scripts (8,9). Besides its role in localization, the 30-UTR of
the actin mRNA has not been extensively studied and
barring EST-based evidence, there exists no experimen-
tally determined polyadenylation (polyA) site in the
actin transcript.
The polyA of eukaryotic transcripts is a two-step enzy-
matically driven process, wherein mRNA is cleaved at a
speciﬁc site and subsequently, the action of polyA poly-
merase, in the presence of a large basal polyA machinery,
adds adenosine nucleotides to the mRNA (10–16). Several
factors like the cleavage and polyadenylation speciﬁcity
factor (CPSF), cleavage stimulation factor (CstF) and
cleavage factors (CFs I and II) perform speciﬁc functions
within the polyA machinery. The polyA is important in
conferring transcript stability (17,18) and translational
eﬃciency (19–23). The polyA tail is also believed to
target the RNA for nuclear export (24,25). Although the
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sequences in the mRNA that specify the site of cleavage
and extent of polyA are not fully characterized. In a
majority of cases, cis-acting elements surrounding the
polyA site act together to specify the cleavage site. The
sequence motif AAUAAA referred to as polyadenylation
signal (PAS) that occurs about 10–30nt (26,27) upstream
of the polyA site in majority of human transcripts (28,29),
binds to the 160kDa subunit of CPSF. However, variants
of the AAUAAA motif can eﬀectively drive polyA (28,29).
Besides the PAS element, G/U or U rich sequences down-
stream to the PAS contribute to the polyA site (30–32) by
binding to the multi-protein CstF.
Recently, bioinformatic analyses of the occurrence of
polyA sites in the human and mouse genomes have
shown a surprisingly large number of alternative polyA
sites (28,33). Large-scale mapping of EST sequences to
the human and mouse genome showed that alternative
polyadenylation is widespread in the mouse and human
genomes. The hexamer motifs present upstream of the
polyA sites identiﬁed by EST analysis vary signiﬁcantly
from the canonical motif, AAUAAA. Ten to thirteen var-
iants of the PAS element account for the polyA sites iden-
tiﬁed over the whole genome. The PAS hexamers
AAUAAA and AUUAAA together account for nearly
69% of all polyA sites in the human genome (28). The
length of the 30-UTR, deﬁned by the distance between
the stop codon and the proximal polyA site was highly
variable with a median length of 324 in humans and
385nt in mouse (28). The frequent occurrence of polyA
sites within internal exons and introns of genes implies
that the use of alternative polyA sites contributes signiﬁ-
cantly to the complexity of the eukaryotic transcriptome.
When the alternative sites occur within protein-coding
regions of the transcript, it can result in functionally dif-
ferent products belonging to the same gene family, as
shown in the case of the Lamin genes (33). Transcripts
coding for the same protein but containing diﬀerent 30-
UTRs may diﬀer in stability, localization, translational
eﬃciency and targeting by small regulatory RNAs. Such
cases called tandem polyA sites (34) have been shown in
several genes and implicated in diﬀerential expression of
transcripts in tissues. For instance, the transcripts from
the huntingtin gene, that causes the Huntington’s neuro-
degenerative disorder, are preferentially polyadenylated at
the distal site in the brain, but truncated at the proximal
polyA site in other tissues (35). Testis, is one of the tissues
in which frequent use of alternative tandem polyA site has
been observed (34). At least two groups have indepen-
dently reported the biased use of alternative polyA sites
in diﬀerent tissues. By mapping ESTs from libraries
derived from diﬀerent tissues, Beaudoing et al. (36)
showed that polyA usage is biased in a tissue- and
disease-related manner. Zhang et al. (37) have also
shown that the usage of polyA sites as well as expression
of protein factors involved in polyA is likely to be diﬀerent
in brain tissues compared to other tissues (37). In spite of
the evidence from large-scale analysis of EST sequences,
characterization of polyA sites and 30-UTR variation in
mammalian transcripts requires detailed experimental
analysis. Experimental proof is lacking for majority of
the predicted alternative polyA events.
Here we used clues from hybridization patterns of probe
sets in high-density oligonucleotide (Aﬀymetrix, CA,
USA) arrays to identify potentially diﬀerentially expressed
transcripts from the actin gene and conﬁrmed it with
experimental analysis and EST mapping. Further analysis
of microarray data and a survey of EST sequences showed
that the cytoplasmic b-actin gene in mouse may use two
tandem polyA sites that are used in a tissue-speciﬁc
manner. We carried out 30-RACE analysis to unambigu-
ously establish the existence of two 30-UTRs of varying
length in actin transcripts. The distal polyA site is asso-
ciated with a perfect PAS element (AAUAAA). Although
a U-rich potential CstF-binding site is present down-
stream to the proximal PAS, no upstream canonical
PAS element could be identiﬁed. On the other hand
although the longer UTR-containing transcript was
expressed at a relatively lower level in neuronal cells, it
conferred higher translational eﬃciency to the transcript
and harbours miRNA target sites. Post-transcriptional
regulation of expression from the longer UTR-containing
transcript is mediated, at least in part by a conserved
mmu-miR-34b-5p/34a target site. LNA-modiﬁed anti-
miRNA against the miRNA, mutations in the miRNA
seed pairing region in the UTR resulted in down-regula-
tion of the target suggesting that the miRNA enhances the
target expression. The expression of the target was
restored using a mutant miRNA complementary to the
mutant target region. Here we provide the ﬁrst evidence
for diﬀerential regulation of alternative transcripts
through miRNA-mediated up-regulation.
MATERIALS AND METHODS
ESTand microarray dataanalysis
Microarray data [accession id: E-HGMP-2, Freilich et al.
(38)] were downloaded from Array express site. Data were
normalized by using Z-score transformation method as
described (39).
Mouse ESTs were downloaded from the Unigene (IDs
Mm.455830, Mm.391967, Mm.328431) and comprised of
a total of 5195 ESTs derived from 43 tissues. 30- Read
ESTs with PAS were parsed using Perl scripts as per the
Unigene annotations. The ﬁnal dataset of 30-read ESTs
with PASs comprised of 203 unique entries. The EST
sequences were mapped back to the genome location
using BLAT using default options. The EST end positions
and the tissues from which they were derived was parsed
using Perl scripts with reference to the gene structure and
positions (UCSC mm9).
RNA isolation
Total RNA was isolated from cultured Neuro-2a cells
using TRIzol reagent (Invitrogen, USA) according to the
manufacturer’s instruction. The RNA pellets were washed
with 70% ethanol, centrifuged and dried. Pellets were
re-suspended in Diethyl pyrocarbonate-treated water fol-
lowed by the addition of 10  reaction buﬀer and RNAse
free DNase I (Fermentas, Germany). Samples were
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using RNeasy Mini Kit (Qiagen, Hilden, Germany) fol-
lowing the protocol by the manufacturer. RNA concen-
tration and purity were determined by measuring optical
density at 260 and 280nm using a spectrophotometer
(Eppendorf, Hamburg, Germany) and separating the
RNA samples on a 1.5% agarose formaldehyde gel.
Rapidamplification of3’-cDNAends (3’-RACE)
cDNA was generated from total RNA sample by using
adapter primer [AP: GGCCACGCGTCGACTAGTAC
(T)17] and M-MuLV reverse transcriptase (New England
Biolabs Inc., UK) at 428C for 1h. Subsequently RNaseH
(Invitrogen) treatment was performed at 378C for 20min.
Touch down (TD) PCR was carried out using the fol-
lowing primers:
(1) GGCATTGCTGACAGGATGCAGAAGG
(gene-speciﬁc primer)
(2) GGCCACGCGTCGACTAGTAC (same as AP
primer except T17 unit)
TD PCR condition was as followed: 948C for 3min;
29 cycles of 948C for 1min, 658C (with reduction per
cycle 0.58C) for 2min, 728C (with elevation per cycle
0.28C) for 1min; then 9 cycles of 948C for 1min, 558C
for 2min and 728C for 2min; then ﬁnal extension of
728C for 7min.
Nested PCR was performed by using primer 2 (above)
and the primer below:
GAAGGAGATTACTGCTCTGGCTCC [Nested
primer for primer (1)]. Nested PCR condition: 958C for
5min, 25 cycles of 948C for 30s, 608C for 30s, 728C for
2min, then ﬁnal extension at 728C for 10min. In this way,
we were able to detect short 30-UTR.
Long 30-UTR was ampliﬁed by using TD PCR product
as template and Primer 2 (above) and long UTR-speciﬁc
primer mentioned below:
GTTTTGGCGCTTTTGACTCAGGATT
PCR condition was 958C for 5min, 35 cycles of 958C
for 10s, 608C for 30s, 728C for 30s, then ﬁnal extension
at 728C for 5min.
PCR products were resolved on a EtBr-stained 2%
agarose gel. Puriﬁed PCR products were cloned in
T-vector (pCR4-TOPO, Invitrogen) and conﬁrmed by
sequencing.
Constructs
Cloning of long- and short-UTR of Actb. The short and
long 30-UTR of murine Actb were ampliﬁed from 30-
RACE product synthesized from Neuro-2a cells. The fol-
lowing primers introduced HindIII (primer 1) and SacI
sites (Primer 2 and 3) in the PCR products (restriction
site underlined):
(1) Reverse primer: AAAAAGCTTGGCCACGCGTCG
ACTAGTAC (common for long and short, contains
sequence of AP)
(2) Forward primer: AAAGAGCTCGTTTTGGCGCTT
TTGACTCAGGATT (for long)
(3) Forward primer: AAAGAGCTCATCGTGCACCG
CAAGTGCTTC (for short)
The gel puriﬁed PCR products were cloned in
HindIII and SacI site of pMIR-REPORTTM vector
(Ambion, Texas, USA), in frame with luciferase and con-
ﬁrmed by sequencing.
Cloning of long UTR in antisense orientation. The long
UTR sequence was ampliﬁed from long UTR construct
(mentioned above) using the following primers:
(1) Forward primer: AAAAAGCTTGTTTTGGCGCTT
TTGACTCAGGATT (HindIII recognition sequence
underlined).
(2) Reverse primer: AAAGAGCTCGGCCACGCGT
CGACTAGTAC (SacI recognition sequence
underlined).
The gel puriﬁed PCR product was cloned in HindIII
and SacI site of pMIR-REPORTTM vector (Ambion),
in frame with luciferase and conﬁrmed by sequencing.
Cloning of mutant versions of long UTR. Mutant versions
(named mut1 and mut2) of long 30-UTR of Actb (long
UTR) were prepared by introducing two base changes
to the miRNA (mmu-miR-34a/b-5p) seed paring region.
The following primers were used for preparing mut1:
(1) FP1: AAAGAGCTCGTTTTGGCGCTTTTGACTC
AGGATT (SacI site underlined).
(2) RP1: AAGTCACTCTACAGGCCAGCCCTGGCT
GCC (mutant bases underlined).
(3) FP2: GGCCTGTAGAGTGACTTGAGACCAATA
AAAGTGCA (mutant bases underlined).
(4) RP2: AAAAAGCTTGGCCACGCGTCGACTAGT
AC (HindIII site underlined).
[Note that primer (2) and (3) have overlapping
regions that include mutant bases.]
PCR reactions were performed using long UTR
construct (mentioned above) as a template. We obtained
PCR product I (482bp) using primer (1) and (2) and PCR
product II (93bp) by using primer (3) and (4). PCR pro-
ducts I and II were then heated at 958C for 20min and
annealed at room temperature for 20min. Annealed pro-
duct was then used as a template and ampliﬁed by using
primer (1) and (4). The gel puriﬁed PCR product was
cloned in HindIII and SacI site of pMIR-REPORT
TM
vector (Ambion), in frame with luciferase and conﬁrmed
by sequencing.
For creating mut2, the following primers were used:
(1) FP1: AAAGAGCTCGTTTTGGCGCTTTTGACTC
AGGATT (SacI site underlined)
(2) RP1: AAGTCAGACTACAGGCCAGCCCTGGCT
GCC (mutant bases underlined)
(3) FP2: GGCCTGTAGTGTGACTTGAGACCAATA
AAAGTGCA (mutant bases underlined)
(4) RP2: AAAAAGCTTGGCCACGCGTCGACTAGT
AC (HindIII site underlined)
[Note that primer (2) and (3) have overlapping
region that includes mutant bases.]
6320 Nucleic Acids Research, 2008, Vol. 36, No. 19Template and PCR reactions were same as mut1 as
described above. The gel puriﬁed PCR product was
cloned in HindIII and SacI site of pMIR-REPORT
TM
vector (Ambion), in frame with luciferase and conﬁrmed
by sequencing.
Cloning of pre-miRNA. Pre-miRNA sequence of mmu-
miR-34b (accession ID MI0000404) was taken from
miRBase. The following overlapping primers were used
for PCR ampliﬁcation of pre-miRNA sequence of mmu-
mir-34b:
(1) Forward primer: TAATCTAGAGGATCCGTGCTC
GGTTTGTAGGCAGTGTAATTAGCTGATTGTA
GTGCGGTGC (BamHI recognition sequence
underlined)
(2) Reverse primer: ATTGAGCTCAAGCTTGTGCC
TTGTTTTTGATGGCAGTGGAGTTAGTGATTG
TCAGCACCGCACTACAATCAGCTAATTA
(HindIII recognition sequence underlined)
The gel puriﬁed PCR product was cloned in HindIII
and BamHI site of pSilencer
TM 4.1-CMV neo vector
(Ambion) and conﬁrmed by sequencing.
Cloning of mmu-miR-34a. The following primers were
used for PCR ampliﬁcation of pre-miRNA sequence of
mmu-miR-34a:
(1) Forward primer: AAAGGATCCtgggaCCAGCTGT
GAGTAATTCTTTGGCAGTGTCTTAGCTGGTT
GTTGTGAGTATTAGC (BamHI sequence under-
lined, let7 ﬂanking sequence in lower case)
(2) Reverse primer: TTTAAGCTTtaggaACAATGTGC
AGCACTTCTAGGGCAGTATACTTGCTGATTG
CTTCCTTAGCTAATACTC (HindIII sequence
underlined, let7 ﬂanking sequence in lower case)
The gel puriﬁed PCR product was cloned in HindIII
and BamHI site of pSilencerTM 4.1-CMV neo vector
(Ambion) and conﬁrmed by sequencing.
Cloning of mmu-miR-34amut. The following overlapping
primers were used for PCR ampliﬁcation
(1) Forward primer: AAAGGATCCtgggaCCAGCTGT
GAGTAATTCTTTGGcACTCTCTTAGCTGGTT
GTTGTGAGTATTAGC (BamHI sequence under-
lined, let7 ﬂanking sequence in lower case, mutant
bases are underlined and italics)
(2) Reverse primer: TTTAAGCTTtaggaACAATGTGC
AGCACTTCTAGGGCACTCTACTTGCTGATTG
CTTCCTTAGCTAATACTC (HindIII sequence
underlined, let7 ﬂanking sequence in lower case,
mutant bases are underlined and italics)
The gel puriﬁed PCR product was cloned in HindIII
and BamHI site of pSilencer
TM 4.1-CMV neo vector
(Ambion) and conﬁrmed by sequencing.
Cell cultureand differentiation
Murine neuroblastoma cells (ATCC number CCL-131;
Neuro-2a or N2a) were maintained in minimum essential
medium (MEM) (GIBCO-BRL) supplemented with
10% fetal calf serum (Biological Industries, Israel),
2mM L-glutamine (Sigma, USA), 1mM sodium pyruvate
(Sigma) and antibiotic–antimycotic solution (100  stock)
(Sigma) at 378C humidiﬁed incubator with 5% CO2.
Human embryonic kidney (HEK) 293T cells were main-
tained in Dulbecco’s modiﬁed eagle’s medium (DMEM)
supplemented with 10% FCS while the rest of the condi-
tions were similar to ones used for the culture of N2a.
Differentiation of Neuro-2a. Approximately 8 10
3 cells
were seeded in each well of a two chambered slide (Lab-
Tek slide Nunc). Cells were maintained in Opti-MEM
(GIBCO-BRL). After 24h media was replaced by
OptiMEM with 5mM N
6,20-o-dibutyryladenosine-30,
50-cyclic monophosphate sodium salt (dbcAMP) (Sigma)
and incubated up to 4–5 days till diﬀerentiation.
Insitu RNA localization
Probe preparation. Digoxigenin-UTP labelled RNA
probes were prepared by in vitro transcription (IVT)
using DIG RNA labelling Kit (T7) (Roche) following
manufacturer’s protocol. Qiagen column puriﬁed PCR
products were used as a template for IVT reaction. The
following primers were used for PCR ampliﬁcation of
UTR regions that was used in IVT reaction for making
sense and antisense probes: T7 promoter sequence has
been underlined, in the primer sequences.
Primers used for detection of both short and long UTR:
RNA probe-a
Anti-sense:
FP: CCAACCGTGAAAAGATGACC
RP: TAATACGACTCACTATAGGGTAACAGTCCG
CCTAGAAGCA
Sense:
FP: TAATACGACTCACTATAGGGCCAACCGTGA
AAAGATGACC
RP: TAACAGTCCGCCTAGAAGCA
Primers used for detection of long UTR:
RNA probe-b
Anti-sense:
FP: GTTTTGGCGCTTTTGACTCAGGATT
RP: TAATACGACTCACTATAGGGGACCAAAGCC
TTCATACATCAAGTT
Sense:
FP: TAATACGACTCACTATAGGGGTTTTGGCGC
TTTTGACTCAGGATT
RP: GACCAAAGCCTTCATACATCAAGTT
Diﬀerentiated cells were ﬁxed with 4% paraformalde-
hyde for 10min, washed four times for 5min with
phosphate buﬀer saline (PBS) supplemented with 0.1%
Tween-20 (PBST). Cells were then incubated in pre-
hybridization buﬀer (50% formamide, 5 SSC, 50mg
ml
 1 yeast t-RNA, 50mgml
 1 heparin, 0.1% Tween-20)
for 1h at 508C. Digoxigenin-labelled RNA probe
was then added and incubated overnight at 508C.
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with wash1 buﬀer (2 SSC, 50% formamide) each with
20min; one wash with wash2 buﬀer (2 SSC, 25mg ml
 1
Rnase A) for 30min at 378C; followed by ﬁve washes
(where SSC buﬀer was diluted in PBST in a stepwise
manner) at room temperature for 15min. Among those
ﬁve washes ﬁrst wash (2 SSC, PBST) was given once,
second wash (1 SSC, PBST) and third wash (0.1 SSC,
PBST) were performed twice. Cells were kept in blocking
solution (2mg ml
 1 BSA, PBST) for 1h at room tempera-
ture and subsequently, incubated with alkaline phospha-
tase conjugated anti-digoxigenin antibody (Roche) (1:300
dilution in PBST) for 30min at room temperature. After
that two washes were given with wash buﬀer (100mM
Tris–Cl, pH 7.5, 150mM NaCl) for 15min at room tem-
perature. Hybridized probes were then detected with
NBT/BCIP solution. After a 5-min wash with PBS cells
were observed under 60 objective (bright ﬁeld) in an
inverted microscope (NIKON).
Transfectionand luciferase assay
Approximately 3 10
5 cells (Neuro 2a) were seeded in
each well of a six-well plate (Axygen) 24h prior to tran-
sient transfection when 50–80% conﬂuency was reached.
Cells were washed once with Opti-MEM (GIBCO-BRL)
and maintained in 1ml Opti-MEM. Equivalent amount of
transfection quality plasmids of vector alone (pMIR-
REPORT
TM), cloned long UTR and short UTR of Actb
(Endo free plasmid maxi kit; Qiagen) were used for trans-
fection using Fugene 6 reagent (Roche) following manu-
facturer’s protocol.
Twenty-four hours after transfection, cells were lysed in
CCLR buﬀer (Promega) and total protein was estimated
using BCA protein estimation kit (Sigma). Luciferase
assay was performed using luciferase assay system
(Promega) and luminescence was measured in a micro-
plate luminometer (Berthold detection system). For data
analysis, luminescence values were normalized to total
protein.
miRNA target predictionand validation experiments
miRNA target prediction was carried out using the
miRanda software (http://www.microrna.org/microrna/).
We used the long UTR sequence as the input and a cut-
oﬀ of predicted G  20kcal/mol.
Neuro-2a cells were co-transfected with luciferase–long
UTR fusion construct and cloned pre-miR-34b. b-Gal
plasmid was also co-transfected for normalization control.
Luciferase–long UTR in antisense orientation fusion
construct/empty vector were used as negative control.
Transfection was performed using Amaxa nucleofection
method as per manufacturer’s protocol.
For LNA experiments approximately 10
5 Neuro-2a
cells per well of a 12-well plate was used for transfection.
Neuro-2a cells were co-transfected with luciferase–long
UTR fusion construct/correspondingly short UTR con-
struct/empty vector along with antisense LNA oligonu-
cleotide (10 40nM)/mock LNA oligo (40nM) and b-gal
control plasmid using NeoFX
TM (Ambion) transfection
reagent following manufacturer’s protocol. Due to the
high level of sequence similarity the antisense LNA
could be able to target both mmu-miR-34b-5p and
mmu-miR-34a. The antisense LNA sequences (modiﬁed
base is underlined) are given below:
(1) ACAACCAGCTAAGA
(2) ACCAATCGACCAAC (Mock LNA or non speciﬁc
LNA)
Twenty-four hours after transfection cells were lysed in
reporter lysis buﬀer (RLB) (Promega) and reporter assays
were performed.
For mutation experiments. Equivalent amount of UTR
construct (longUTR/mut1/mut2) was transfected to
Neuro-2a cells using 3ml lipofectamine (Invitrogen)
following manufacturer’s protocol. b-Gal control plasmid
was co-transfected for normalization. Cells (10
5/well)
were plated in 12 well plates before transfection.
Twenty-four hours after transfection, cells were harvested
for luciferase and b-gal reporter assays.
For compensatory mutagenesis experiments. Approxi-
mately 400ng of long UTR construct/mut2, 400ng of
cloned pre-miR-34a/pre-miR-34amut and 200ng of b-gal
control plasmid were co-transfected into HEK 293T cells
using 3ml lipofectamine (Invitrogen) following manufac-
turer’s protocol. Cells (10
5/well) were plated in 12 well
plate before transfection. Cells were harvested for reporter
assays 24h after transfection.
Reverse transcriptionfollowed by PCR
Total RNA was isolated from Neuro-2a cells transfected
with luciferase–long UTR fusion construct/luciferase–
short UTR construct/empty vector that contains luciferase
reporter. RNA isolation method and DNase treatment
have been described above. Total RNA was reverse tran-
scribed by using random hexamer and M-MuLV reverse
transcriptase (New England Biolabs Inc). cDNA was then
PCR ampliﬁed by using luciferase-speciﬁc primers (FP:
CTCGGGTGTAATCAGAAT, RP: TTTACACGAAA
TTGCTTCT) and 18S rRNA speciﬁc primers (FP:
CTTTCGAGGCCCTGTAATTG, RP: CCTCCAATGG
ATCCTCGTTA).
Real time PCR
Real time PCR was performed by using Taq
RMan probe
speciﬁc for mmu-miR-34, miR-92 using Taq
RMan
microRNA assay kit (Applied Biosystems) following man-
ufacturer’s protocol. Taq
RMan probes for mmu-miR-34
and miR-92 were purchased from Applied Biosystems.
Data were analysed using relative quantiﬁcation method.
miR-92 was used as an endogenous control as per manu-
facturer’s instruction.
Primer extension
Primer extension was performed from 1mg of total RNA,
a-P-32-dCTP, and the following reverse primers:
(1) ACAACCAGCTAAGA (for mmu-miR-34a)
(2) TGCTAATCTTCTCTGTATCG (for mmu-miR-92)
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Inc) was used for primer extension method. Samples were
resolved in 20% polyacrylamide gel containing urea (8M).
Radiolabelled gel was scanned in a phosphorimager.
RESULTS
The high-density oligonucleotide array for mouse genome
generated by Aﬀymetrix, Mouse U74Av2 includes ﬁve
probe sets complementary to actin. Three probes
(M12481_5_at, M12481_M_at and M12481_3_at)
included in this and subsequent versions of the array are
complementary to 50, middle and 30 parts of the coding
region. These probe sets are included on the array as con-
trol probes for housekeeping genes and are expected to
show high level of signal after hybridization. Two addi-
tional probe sets (101578_f_at, 95705_s_at) are also anno-
tated as corresponding to ‘cytoplasmic b-actin gene
(Actb)’, but they are complementary to regions 165bp
downstream to the reported 30-end of the actin transcript
(Figure 1). Each probe set consists of overlapping oligo-
nucleotides that cover a part of the Actb gene. The
sequences corresponding to the ﬁve probe sets are pro-
vided in Supplementary Figure 1.
In mouse neuronal gene expression proﬁling experi-
ments carried out in our lab previously (data not
shown), we found that the two probe sets complementary
to the Actb downstream region also showed detectable
signals. However, the signal was much lower than the
signals from the three control probes. This provided an
indication that Actb gene may be associated with hetero-
genous 30-UTRs. We examined the signals from all ﬁve
probes in microarray data generated using U74Av2
arrays from Gene Expression Omnibus (GEO), the micro-
array data repository hosted by NCBI. There are more
than 4000 experiments using the GPL81 platform corre-
sponding to the U74Av2 in GEO. We observed that the
expression of the three Actb internal probes were consis-
tently higher than the signals from the two downstream
probe sets. To explore tissue-speciﬁc expression diﬀerences
between the probes, we used the tissue-speciﬁc expression
data proﬁling carried out by Freilich et al. (38). We found
that the three internal probes give a consistently high
expression level whereas the 30-UTR-speciﬁc probes
showed highly variable expression in diﬀerent tissues
(Figure 2). In tissues like pre-putial gland, pyloric
andrus and vas deferens, it showed a signal comparable
to the high signal of the internal control probe sets, in
tissues like appendix, brain and testes medium-level
expression was seen whereas extremely low signals were
seen in colon and lung. This observation also ruled out the
possibility that the 30-UTR-speciﬁc probes simply hybrid-
ize less eﬃciently than the internal probes.
We next carried out EST analysis to validate the results
from microarray analysis. ESTs reported from the actin
gene locus were systematically analysed to identify longer
transcripts which may account for the signal from the
downstream probes in the microarrays. The EST analysis
revealed two distinct clusters of EST ends in the 30-UTR
of Actb gene, corresponding to the two alternative polyA
sites (Figure 3A). The former cluster comprised of a total
of 63 ESTs and the latter 122 ESTs. Members of each
cluster were further analysed for the tissue of origin
using the Unigene annotations (Figure 3B). Brain tissue
showed enrichment for the ﬁrst cluster of ESTs while the
latter showed enrichment in the embryonic tissues and
mammary gland.
We experimentally veriﬁed the presence of alternative
30-UTRs in cytoplasmic b-actin transcripts. Total RNA
isolated from Neuro-2a cells was reverse transcribed to
synthesize cDNA and PCR ampliﬁcation using a
common forward primer and alternative 30-UTR-speciﬁc
reverse primers revealed the presence of transcripts of
varying abundance (Figure 4A). The common forward
primer spans the exon junction between the last and penul-
timate exons. One of the reverse primers is complementary
to the region 2bp following the stop codon and results in a
short 190bp product. This primer can bind to cDNA pro-
ducts from both short and long transcripts. A second
reverse primer that binds to the region 259bp downstream
to the stop codon was also included in the analysis. This
primer is positioned beyond the predicted proximal polyA
site and can bind only to the long transcripts. The 450bp
product arising from this primer reﬂects the abundance of
the long transcript, whereas the abundance of the short
190bp product represents the collective expression level of
short and long transcripts from the Actb gene. These
RT–PCR results, in agreement with the microarray and
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Figure 1. Mouse cytoplasmic b-actin (Actb) speciﬁc antisense hybridization probe sets were mapped on the Actb sequence, a pictorial depiction.
M12481_5_at, M12481_M_at, M12481_3_at, 95705_s_at, 101578_f_at are Actb speciﬁc antisense probe sets in Aﬀymetrix U74Av2 mouse Genechip.
M12481_5_at, M12481_M_at, M12481_3_at are complementary to the coding region of Actb transcript while 95705_s_at, 101578_f_at are com-
plementary to the 30-UTR region. The nucleotide sequence corresponding to each probe sets are given in Supplementary Figure 1.
Nucleic Acids Research, 2008, Vol. 36, No. 19 6323EST analyses showed, without doubt, that mouse neuro-
nal cells express 30-UTR variants of Actb transcripts. To
unambiguously assign the exact 30-end of the Actb gene,
we used the classical 30 rapid ampliﬁcation of cDNA ends
(RACE) methodology. We carried out 30-RACE for actin
transcripts using total RNA isolated from the mouse neu-
ronal cell line Neuro-2a. The total RNA was used for
cDNA synthesis primed by a oligodT primer carrying a
50 GC-rich AP. The extended region of the AP serves as a
reverse primer-binding site for subsequent rounds of PCR
ampliﬁcation using gene-speciﬁc forward primers and a
common reverse primer. Subsequently, the PCR products
were cloned and sequenced. We isolated two distinct types
of clones in 30-RACE experiments that allowed us to
unambiguously establish the existence of two alternative
transcription stop sites in the Actb gene. The proximal
stop site results in a short 30-UTR of 59bp that is highly
conserved from chicken to human and includes the 54nt
zipcode sequence (Supplementary Figure 2). A gene-
speciﬁc forward primer positioned 179bp upstream from
the translation stop site, resulted in the  290bp
short product (Figure 4B) expected from the proximal
Figure 3. EST end analysis of Actb transcript revealed two distinct clusters of transcripts corresponding to the two polyA sites (A). The tissue of
origin of ESTs in each cluster (B) showed that the ESTs were diﬀerentially expressed in diﬀerent tissues. The scale bar represents abundance of ESTs.
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Figure 2. Tissue-speciﬁc expression of cytoplasmic b-actin (Actb). Microarray data (38) was reanalysed and normalized values of Actb speciﬁc probes
were plotted. Antisense probe sets corresponding to coding region (M12481_5_at, M12481_M_at, M12481_3_at) and 30-UTR (95705_s_at,
101578_f_at) of Actb are obtained from Aﬀymetrix U74Av2 mouse Genechip.
6324 Nucleic Acids Research, 2008, Vol. 36, No. 19Figure 4. Reverse transcription followed by PCR (RT–PCR) (A) and 30-RACE (rapid ampliﬁcation of cDNA 30-ends) analyses revealed the existence
of short (B) and long polyA variant (C) of Actb in mouse neuronal cells. Forward (FP) and reverse (RP) primers (arrow heads) for PCR
ampliﬁcation in RT–PCR analysis were shown by pictorial depiction (A) where FP was an intron spanning primer common for both short and
long transcript, E5 and E6: exon 5 and 6, respectively, intronic region between E5 and E6 not shown. Gene-speciﬁc FP and AP for 30-RACE analysis
were described in Materials and methods section. The intensity of each band in A, left panel was quantiﬁed and plotted (A, right panel) relative to
long UTR-speciﬁc band. Data represent mean SD of two independent experiments performed. (D)3 0-RACE products were sequenced and ﬁrst and
second cleavage sites (ﬁlled inverted triangle), FP used in RACE for amplifying long UTR (right arrow), Aﬀymetrix probe sets 95705_s_at (under-
lined) and 101578_f_at (dashed line), Zip code (italics) demarcated on the 30-UTR sequence. Nucleotide that diﬀers from Genebank sequence was
indicated as (slash). M: DNA marker, S and L: transcript bearing short 30-UTR and long 30-UTR, respectively. RT+: with reverse transcriptase,
RT :without reverse transcriptase.
Nucleic Acids Research, 2008, Vol. 36, No. 19 6325polyA site. However, in mouse neuronal cells we also
found, additionally, actin transcripts with a much longer
30-UTR of 678bp. The gene-speciﬁc forward primer was
designed to bind a region between the two polyA sites so
that it would amplify only the cDNA products of the long
transcripts and result in a  550bp product (Figure 4C).
The longer transcript includes regions homologous to the
two downstream probes (101578_f_at, 95705_s_at) on
the Aﬀymetrix array. Figure 4D provides an overview of
the sequence elements in the 30-UTR of the actin tran-
script along with the positions of the Aﬀymetrix probe
sets mentioned here, and the polyA sites identiﬁed in
our RACE experiments.
Our RT–PCR analysis implied that the longer tran-
scripts were less abundant than the short transcript.
However, to rule out the possibility that the PCR product
abundance may be aﬀected by the eﬃciency of PCR, we
carried out in vivo expression analysis. We performed
in situ hybridization using probes speciﬁc to the long
UTR and common to both transcripts in neuronal cells
to look for diﬀerential localization of the longer actin
transcript. As shown in Figure 5, both long transcript
speciﬁc antisense probe and the common antisense probe
showed cytoplasmic localization while sense probes failed
to show any signal. The signal from the common antisense
probe that can bind to both long and short transcripts was
consistently higher than the signal from the long transcript
speciﬁc probe. Therefore, in keeping with the microarray
data, the longer transcript seems to be less abundant in
neuronal cells.
We cloned the short and the long UTR regions
(Figure 6A) isolated in our RACE experiments down-
stream of the luciferase reporter gene driven by the
highly and constitutively expressed CMV promoter. The
luciferase activity per unit total protein showed that
the long 30-UTR region conferred 2.4-fold higher steady
state expression level of the reporter as compared to the
vector transfected controls (Figure 6B). The expression
level of the reporter from the short UTR-reporter fusion
construct was reduced to nearly half of the vector control.
The relative diﬀerence in luciferase activity between the
short and long 30-UTR clones was 4.3-fold. The diﬀerence
in reporter activity seems to arise from diﬀerential tran-
script stability since the luciferase transcript levels normal-
ized to 18S rRNA levels, in RT PCR experiments, showed
relatively higher levels of the long UTR transfected cells
(Figure 6D). The additional 515bp in the longer transcript
seems to harbour sequences that stabilize the transcript
or improve translational eﬃciency, since protein levels
from the reporter gene are signiﬁcantly higher in
the cells expressing the long transcript fused to the
reporter gene.
A  B 
C  D 
Figure 5. Existence of polyA variants of Actb in diﬀerentiated mouse neuronal cell analysed by in situ hybridization. Diﬀerentiated Neuro-2a
cells were hybridized with digoxigenin-UTP labelled antisense RNA probe-a (A), sense probe-a (C), antisense RNA probe-b (B), sense probe-b
(D). Antisense RNA probe-a: antisense probe that can detect both short and long polyA variants; antisense RNA probe-b: antisense probe speciﬁc
for long polyA variant (scale bar, 100mm).
6326 Nucleic Acids Research, 2008, Vol. 36, No. 19We next looked for potential microRNA target sites in
the 30-UTR region of Actb. Using miRanda, we predicted
mmu-miR-34b-5p and mmu-miR-505 binding sites
(Figure 7) in the long UTR of Actb transcript, down-
stream to the proximal polyA sites. Figure 7 provides a
schematic representation of the sequence features identi-
ﬁed in the actin 30-UTR sequence, including localization
signals, miRNA binding sites experimentally identiﬁed
polyA sites and associated sequence elements. On closer
inspection, it was seen that the mmu-miR-34a and mmu-
miR-34b-5p had identical seed sequences and therefore
both could potentially target the same site. We checked
the evolutionary conservation at these sites, since func-
tional miRNA target sites in the 30-UTR are likely to
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Figure 6. Eﬀect of short and long 30-UTR sequence on translation. (A) Sequence region of short and long 30-UTR of Actb was cloned (see Materials
and Methods section) in a pmirReport vector (Ambion) containing luciferase as a reporter. Cloned region of short- and long-UTR were pictorially
described (A) by primer sets where reverse primer was AP used for RACE; short- and long-UTR-speciﬁc forward primers were denoted by S and L,
respectively, followed by arrow heads. (B) Translational eﬀect of UTR sequences were determined by luciferase assay, 24h after transfection cells
were lysed and luminescence were counted in a luminometer. Data were normalized to total protein and represented relative to vector transfected
control. Data shown are mean SEM of four independent experiments, in replicate performed. (C, D) Eﬀects of UTR sequences on mRNA level
were checked by RT–PCR (D). Total RNA was isolated from cells 24h after transfection and reverse transcribed, further luciferase (reporter) and
18S rRNA speciﬁc primers were used for PCR to check mRNA level and loading control, respectively. Luciferase speciﬁc primers were shown (C).
Figure 7. Annotation of 30-UTR of mouse cytoplasmic b-actin (Actb) reference sequence along with short and long polyA variants. pA: polyA site.
Nucleic Acids Research, 2008, Vol. 36, No. 19 6327show higher conservation than regions that do not har-
bour functional elements. The mmu-miR-34b-5p/34a
target site was highly conserved amongst vertebrates
(Supplementary Figure 3A), while the mmu-miR505 site
is deleted in the human homologue (Supplementary
Figure 3B). We also saw that in Drosophila, dre-miR-34,
shows a potential binding site in the actin transcript (data
not shown). Due to poor conservation of the target site,
mmu-miR-505 was not validated further. In summary, the
longer transcript arising from the distal polyA site seems
to be less abundant, translationally more eﬃcient and
potentially targeted by mmu-miR-34b-5p/34a.
We attempted to study the role of miRNA-mediated
regulation on the long UTR of Actb by over expressing
the pre-miRNA. We expressed pre-miR-34b under the
CMV promoter in Neuro-2a cells along with the lucifer-
ase–UTR fused constructs. Cells expressing the miRNA
and long UTR construct showed a modest up-regulation
(statistically signiﬁcant P-value <0.05, Student’s t-test) of
luciferase reporter. The long UTR in the antisense orien-
tation was not aﬀected (P-value >0.05, Student’s t-test)
as compared to mock (pSilencer negative control vector)
transfected control (Figure 8). Next, we used anti-miRNA
molecules to study the eﬀect of down-regulation of
endogenous mmu-miR-34a/34b-5p. The high sequence
similarity between miR-34a/34b-5p sequences allows the
anti-miRNA molecule to target both mmu-miR-34a and
mmu-miR-34b-5p. We have earlier compared unmodiﬁed
and locked nucleic acid (LNA) modiﬁed oligonucleotides
for this purpose and found that LNA modiﬁcation
results in higher aﬃnity for the target miRNA sequence
and interference at lower concentration minimizing non-
speciﬁc and toxic eﬀects (unpublished result). Anti-
miRNA molecules resulted in up to 3-fold down-regula-
tion of expression from long UTR whereas short UTR
remained unaﬀected (Figure 9). Endogenous mmu-miR-
34a/34b-5p, therefore, mediates higher expression from
the long UTR.
To study the eﬀect of mmu-miR-34a/34b-5p in further
details, we created two mutants constructs each carrying
two mutations in the miRNA target region (Figure 10A
and B). The mut1 construct carried two mutations in the
target region, at adjacent positions in the middle of the
seed region. Mutations in the middle of the seed region are
expected to result in maximum destabilization of the
miRNA target binding. The mut2 construct also carried
two mutations disrupting two G-C bonds in the miRNA
target binding. As shown in Figure 10C, both 30-UTR
mutations resulted in reduced expression of the luciferase
reporter conﬁrming that the miRNA target region med-
iates high expression of the long UTR of the mouse Actb
gene in neuronal cells. The mut2 construct showed mar-
ginally higher eﬀect resulting in nearly 60% reduction in
expression compared with the long UTR construct. We
next created constructs bearing mutant pre-mmu-miR-
34a with mutations that would restore binding to mut2
construct. We incorporated ﬁve bases from the let-7
miRNA ﬂanking regions adjacent to the pre-miRNA to
ensure over expression of the miRNA. The expression of
the mature miRNA was veriﬁed by quantitative real time
PCR (Supplementary Figure 4). In cells over-expressing
wild-type mmu-miR-34a, consistent with Figure 10C,
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Figure 8. mmu-miR-34 dependent regulation of long 30-UTR variant of
Actb in Neuro-2a cells. Long UTR-speciﬁc region was cloned into
pmirReport vector (Ambion) that contains luciferase as a reporter
under CMV promoter. Long UTR was cloned in anti-sense orientation
into the same vector. Pre-miRNA of mmu-miR-34b was cloned into
pSilencer 4.1-CMV neo vector (Ambion). Neuro-2a cells were co-trans-
fected with long UTR construct/long UTR anti-sense orientation con-
struct/empty vector along with pre-miR-34b construct/mock. pSilencer
vector (Ambion) was used as negative control (mock). Twenty-four
hours after transfection cells were harvested for assays. Reporter (lucif-
erase) activity was normalized to the activity of a co-transfected CMV-
b-galactosidase construct. Data represented the mean SEM of two
independent experiments, each in duplicate, performed. (
 P<0.05,
Student’s t-test).
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Figure 9. Inhibition of mmu-miR-34a/b by transfection of antisense
LNA oligonucleotide leads to the down-regulation of long 30-UTR
variant of Actb in a concentration dependent manner. Antisense
LNA oligonucleotide was designed against both mmu-miR-34b-5p/
34a; and co-transfected with UTR constructs of Actb and empty
vector into Neuro-2a cells. A non-speciﬁc LNA was used as a negative
control (mock). Twenty-four after transfection cells were harvested
for assays. Reporter (luciferase) activity was normalized to the activity
of a co-transfected CMV-b-galactosidase construct. Data represented
the mean SEM of two independent experiments, each in duplicate,
performed.
6328 Nucleic Acids Research, 2008, Vol. 36, No. 19the mut2 construct showed lower expression levels com-
pared to the long UTR. The expression of the reporter was
restored when the mut2 construct was expressed with
the mutant mmu-miR-34a bearing compensating muta-
tions that allow miRNA target binding (Figure 10D).
Therefore, mmu-miR-34a mediates up-regulation of the
long UTR of the Actb gene.
DISCUSSION
Recent bioinformatics studies have shown that nearly
50% of genes in the human genome may harbour alter-
native polyA sites (33). Heterogeneity in 30-UTRs can
therefore account for diﬀerential regulation, stability and
spatio-temporal expression of transcripts from the same
gene. We have used EST and gene expression data,
30-RACE analysis and in situ hybridization to establish
that the cytoplasmic b-actin gene generates two alternative
transcripts terminated at tandem polyA sites. Our analysis
indicates that the longer transcripts are regulated in a
tissue-speciﬁc manner, whereas the proximal polyA site
is used for constitutive expression. Functionally, the
longer UTR confers higher stability on the transcript,
resulting in higher reporter gene expression, in mouse neu-
ronal cells. Besides its highly conserved housekeeping
function, the Actb gene plays diverse roles. It has been
suggested that variable 30-UTRs may contribute to the
complexity of transcriptome and provide a mechanism
for diﬀerential regulation in a tissue-speciﬁc manner
(37). The existence of tandem polyA site and heteroge-
neous 30-UTRs in the well-studied Actb gene provides
experimental support for the involvement of 30-UTR in
tissue-speciﬁc gene expression.
We explored the sequences surrounding the polyA site
for conserved motifs that have been shown to ﬂank
the cleavage site. The polyA is carried out by the polyA
polymerase in mammalian cells in a highly regulated
manner, through a complicated mechanism involving
Figure 10. Mutation in the miRNA (mmu-miR-34a/b-5p) binding site of long 30-UTR of Actb aﬀects translation. (A and B) Mutant versions
(named mut1 and mut2) of long 30-UTR of Actb (long UTR) were prepared by introducing two base changes (indicated by arrows) to the miRNA
(mmu-miR-34a/b-5p) seed paring region. (C) Translational eﬀect of mutation in the miRNA seed pairing region of long UTR was analysed by
reporter (luciferase) assay. Neuro-2a cells transfected with long UTR/mut1/mut2 were harvested for assay after 24h of transfection. Reporter
(luciferase) activity was normalized to the activity of a co-transfected CMV-b-galactosidase construct. Normalized luciferase activity was represented
relative to the long UTR transfected control. Data shown are mean SEM of two independent experiments performed. (
 P<0.05, Student’s t-test).
(D) Mutations in the seed region of mmu-miR-34a compensate for mutation in the target region of long UTR; indicates a direct eﬀect of mmu-miR-
34a on Actb long UTR. Mutant version of mmu-miR-34a (named mmu-miR-34amut) was prepared by introducing two base changes (indicated by
arrows) complementary to the mutations in mutant version of long UTR (mut2). HEK 293T cells were co-transfected with long UTR/mut2 along
with cloned mmu-miR-34a/mmu-miR-34amut and cells were harvested for assays after 24h of transfection. Reporter (luciferase) activity was normal-
ized to the activity of a co-transfected CMV-b-galactosidase construct. Normalized luciferase activity was represented relative to the long UTR
transfected control. Data shown are mean SEM of three independent experiments performed (
 P<0.05,
  P<0.01, Student’s t-test).
Nucleic Acids Research, 2008, Vol. 36, No. 19 6329multi-protein complexes that interact with these sequences
on either side of the cleavage site. The most well-charac-
terized sequence element that signals polyA sites is the
AAUAAA motif found within 10–30nt upstream of the
cleavage site (26,27). The distal polyA site is associated
with a canonical PAS element followed by downstream
G/U rich sequences and has been bioinformatically iden-
tiﬁed in whole genome studies. We did not ﬁnd a canonical
polyA element upstream of the short transcript. The
AAUAAA sequence can account for only about 53% of
all the known polyA sequences in the genome (28). The
major sequence variant of the PAS element, AUUAAA,
accounts for an additional 16% of all polyA sites pre-
dicted by EST mapping (28). Several genes harbour
other variants of the polyA site, although they vary in
strength and maybe enhanced by the presence G/U or U
rich sequences downstream. Nearly 13 most frequently
occurring variants of the PAS site have been identiﬁed
by large-scale analysis of polyA sites in the human and
mouse genomes (28,29). Although the canonical PAS ele-
ment is not seen with 40nt upstream of the proximal
polyA site, we found a UUUACA hexamer at 31nt
upstream of the proximal site. This hexamer has a single
substitution at the ﬁfth position from the hexamer
UUUAAA which is amongst the 10 most frequently
found hexamers reported in previous studies. There is a
strong U rich region 35nt downstream of the proximal
cleavage site that may enhance use of the non-canonical
upstream signal.
EST and microarray analysis indicated that the long
transcript is highly expressed in embryonic and germinal
tissue, since detection levels were high in pre-putial gland,
vas deferens and testes (microarray analysis) and embry-
onic tissue and mammary gland (EST analysis). The whole
brain showed a medium level of expression of the long
transcript in microarray and EST data whereas it was
poorly expressed in other tissues. The inclusion of several
cell types in whole brain samples and the resultant hetero-
geneous nature of whole brain RNA can result in dilution
of expression level of transcripts that maybe expressed in a
speciﬁc subpopulation of neuronal cells. The actin tran-
script has been shown to undergo rapid deadenylation
during early developmental stages in mouse embryos
(8,9). In neuronal cells, the actin transcript is localized
to the synapses as part of ribo-nucleoprotein bundles
(40). Transient localization of actin transcripts following
exposure to neutrophins and brain-derived neurotrophic
factor (BDNF) indicates that it has an important step in
directed growth of axons and synaptic connectivity (41).
The localization of actin transcript requires a sequence
element called the zipcode (7). Reporter b-galactosidase
fusion to the zipcode results in localization of lacZ expres-
sion to sites of actin polymerization at the periphery
of chick ﬁbroblast cells (7). The zipcode is a conserved
54 nucleotide long sequence that occurs in chick, dog,
mouse and human actin transcripts, immediately follow-
ing the stop codon. Both the short and long UTRs identi-
ﬁed in our study, contain the zipcode sequence. The
heterogeneity in the UTR apparently does not disrupt
the localization signal. However, the structural basis of
the binding of the zipcode binding factor (ZBF) to the
localization signal has not been studied. The additional
regions in the longer transcript could potentially alter
the secondary structure of the transcript and modulate
the localization of actin mRNA to the cell periphery.
Our in situ hybridization results serve to demonstrate the
in vivo presence of the longer transcript in neuronal cells
and provide a basis for studying speciﬁc localization of
these transcripts to growth cones of axons following treat-
ment with external agents like neutrophins and BDNF.
The longer UTR harbours target sites for regulation by
small regulatory RNAs. MicroRNAs are 21–23nt long
regulatory RNAs that can bind to target sites of partial
complimentarity within UTRs and interfere with tran-
script stability or translational eﬃciency. Alternative
polyA at tandem sites can result in transcripts coding
for the same protein with diﬀerential susceptibility to
miRNA-mediated regulation at the translational level.
We found that the longer actin transcript harbours poten-
tial binding sites for mmu-miR-34a/34b-5p and mmu-miR
505. The human, mouse and rat transcripts show high
level of conservation at the miR-34a/34b-5p binding
sites, implying that these sites are functional. We observed
a pronounced dose dependent down-regulation of luci-
ferase reporter activity in cells transfected with LNA
modiﬁed anti-miR-34a/34b-5p oligonucleotides and luci-
ferase–long UTR fusion construct. Moreover, compensa-
tory mutagenesis of the miRNA and target conclusively
showed the positive eﬀect of the miRNA on target expres-
sion. Taken together, these results allow us to attribute a
mmu-miR-34b-5p/34a mediated positive eﬀect on expres-
sion from the long UTR of Actb. miRNAs are generally
believed to have a repressive eﬀect on target molecules.
Although rare, miRNAs have earlier been shown to medi-
ate a positive regulatory eﬀect in specialized conditions.
For instance, the hsa-miR-369-3p binds to AU rich ele-
ments (ARE), in the 30-UTR of tumour necrosis factor-a
(TNF-a) transcript, recruits speciﬁc proteins and activates
translation under growth arrest conditions (42). A similar
miRNA-mediated up-regulation of target transcript has
been demonstrated by Let-7at the 30-UTR of high mobi-
lity group A2 (HMGA2) (42). mmu-miR-34a/34b-5p
mediated up-regulation of Actb long UTR transcript is
part of a growing body of evidence that miRNA can
mediate repressive as well as inducing eﬀect on gene
expression.
In lower organisms like Drosophila, the miR-34 family
consists of a single miRNA whereas in human, it is repre-
sented by highly similar sequence variants hsa-miR-34a, b
and c (43). The human miRNA, hsa-miR-34a can be
induced by ionizing radiation and DNA damage agents
in a p53-dependent manner (44,45). It has been shown to
be highly expressed in pancreatic cancers, actively partici-
pate in the p53 tumour suppressor pathway (46,47).
Its targets include Notch, Delta1 and the transcription
factor E2F3, besides the anti-apoptotic gene bcl2 (48,49).
The existence of mmu-miR-34a/34b-5p target sites in the
long UTR of Actb implies that further experimental anal-
ysis of diﬀerential expression of the 30-UTRs in cancers
can be important. The actin transcript has been found in
ribonucleoprotein complexes in neuronal synapses, but
miR-34 was not found to be abundant in cell neurites,
6330 Nucleic Acids Research, 2008, Vol. 36, No. 19in the ﬁrst study to identify miRNAs localized to the
neurites (50). Further studies of co-localization of the
mRNA and miRNA in axons and dendrites of speciﬁc
neuronal cells may reveal the functional relevance of the
30-UTR heterogeneity in Actb transcripts.
In summary, our studies unambiguously establish the
presence of tandem alternative polyA sites and 30-UTRs
of diﬀerent tissue-speciﬁc expression pattern in Actb
mRNA transcripts. This is the ﬁrst report of heterogeneity
in transcripts of the Actb gene, widely held to be a con-
stitutively and ubiquitously expressed housekeeping gene.
It supports the ﬁndings of several bioinformatics studies
that uncovered the extensive occurrence of polyA sites in
the genome. Furthermore, this study illustrates that the
integrated analysis of microarray data, EST data and
miRNA target prediction can provide novel insights into
diﬀerential regulation and functional importance of alter-
native polyA in the genome. The approach used here, of
using diﬀerential hybridization signals from diﬀerent
probe sets to identify alternative splicing and polyA can
be used further for genome-wide bioinformatics analysis.
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